BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 3772905)

  • 1. Pharmacology of estrogens and estrogen-induced effects on nonreproductive organs and systems.
    Gorrill MJ; Marshall JR
    J Reprod Med; 1986 Sep; 31(9 Suppl):842-7. PubMed ID: 3772905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonoral routes of estrogen administration.
    Cedars MI; Judd HL
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):269-98. PubMed ID: 3306522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncontraceptive estrogen use and cardiovascular disease.
    Bush TL; Barrett-Connor E
    Epidemiol Rev; 1985; 7():89-104. PubMed ID: 2996919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estrogen therapy for the climateric and thromboembolic risk].
    Campagnoli C; Prelato L; Rossetti MG
    Minerva Ginecol; 1980 May; 32(5):429-35. PubMed ID: 7393492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney.
    Li JJ; Li SA; Klicka JK; Parsons JA; Lam LK
    Cancer Res; 1983 Nov; 43(11):5200-4. PubMed ID: 6616455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
    Schindler AE; Bolt HM; Zwirner M; Hochlehnert G; Göser R
    Arzneimittelforschung; 1982; 32(7):787-91. PubMed ID: 6289846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
    Batzer FR
    J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral contraceptives and metabolic changes].
    Lara Ricalde R; Aznar Ramos R
    Ginecol Obstet Mex; 1986 Aug; 54():212-5. PubMed ID: 3781292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sex steroids and vascular risk].
    Rozenbaum H
    Coeur; 1983; 14(1):91-102. PubMed ID: 12339512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic and pharmacologic effects of estrogen and progestins on bone.
    DeCherney A
    J Reprod Med; 1993 Dec; 38(12 Suppl):1007-14. PubMed ID: 8120857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics and pharmacology of estrogens in pre- and postmenopausal women.
    Anderson F
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():55-64. PubMed ID: 8499960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and bone. Marshall R. Urist's contributions.
    Gordan GS
    Clin Orthop Relat Res; 1985 Nov; (200):174-80. PubMed ID: 3905109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sex hormone replacement following menopause--for all women? A plea for prevention using estrogens and gestagens].
    Nocke W
    Ther Umsch; 1995 Oct; 52(10):693-704. PubMed ID: 7482382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogens in oral contraceptives: historical perspectives.
    Goldzieher JW
    Johns Hopkins Med J; 1982 May; 150(5):165-9. PubMed ID: 7043034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
    Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroids and lipid metabolism: mechanism of action.
    Basdevant A
    Int J Fertil; 1992; 37 Suppl 2():93-7. PubMed ID: 1354664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral contraception: failures and risks].
    Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects.
    Helgason S
    Acta Obstet Gynecol Scand Suppl; 1982; 107():1-29. PubMed ID: 6282033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption and metabolic effects of different types of estrogens and progestogens.
    Lobo RA
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):143-67. PubMed ID: 3306517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.